Pharsight Monthly Summary
DECEMBER, 2022
Recent happenings in patent protected drugs.
spacer_11
At a Glance
50
drug patents lapsed
Photos
68
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
ABBVIE
 
ALMIRALL
 
ALNYLAM PHARMS INC
 
AMNEAL
 
ANTARES PHARMA INC
 
ASTELLAS
 
ASTRAZENECA
 
AXSOME
 
AZURITY
 
BIOMARIN PHARM
 
BRISTOL
 
CHIESI
 
CYCLE
 
ELI LILLY AND CO
 
EPIZYME INC
 
EXELTIS USA INC
 
FENNEC PHARMS INC
 
HIKMA
 
INCYTE CORP
 
LANTHEUS MEDCL
 
MAYNE PHARMA
 
OTTER PHARMS
 
RIGEL PHARMS
 
RVL PHARMS
 
SALIX
 
VERTEX PHARMS INC
 
VIFOR FRESENIUS
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ARNUITY ELLIPTA GLAXOSMITHKLINE
AXUMIN BLUE EARTH
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
ORBACTIV MELINTA THERAP
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VIIBRYD ABBVIE
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
AMITIZA 6982283 Dec, 2022
ANJESO 8512727 Dec, 2022
DORYX 6958161 Dec, 2022
DORYX 6958161 Dec, 2022
DORYX 6958161 Dec, 2022
DORYX 6958161 Dec, 2022
DORYX 6958161 Dec, 2022
DORYX 6958161 Dec, 2022
DORYX MPC 6958161 Dec, 2022
DORYX MPC 6958161 Dec, 2022
EPIDUO 8105618 Dec, 2022
EPIDUO 8241649 Dec, 2022
EPIDUO 8809305 Dec, 2022
EPIDUO 8936800 Dec, 2022
EPIDUO FORTE 8445543 Dec, 2022
EPIDUO FORTE 8785420 Dec, 2022
EPIDUO FORTE 8809305 Dec, 2022
EPIDUO FORTE 8909305 Dec, 2022
EPIDUO FORTE 8936800 Dec, 2022
EPIDUO FORTE 9814690 Dec, 2022
HETLIOZ 5856529 Dec, 2022
HETLIOZ LQ 5856529 Dec, 2022
OFORTA 7148207 Dec, 2022
PATADAY ONCE DAILY RELIEF 7402609*PED Dec, 2022
RYANODEX 8110225 Dec, 2022
SAXENDA 8846618*PED Dec, 2022
TOBI PODHALER 7368102 Dec, 2022
TOBI PODHALER 8715623 Dec, 2022
TOBI PODHALER 9421166 Dec, 2022
VARUBI 8796299 Dec, 2022
VARUBI 8796299 Dec, 2022
VICTOZA 8846618*PED Dec, 2022
VIIBRYD 7834020*PED Dec, 2022
VIIBRYD 8193195*PED Dec, 2022
VIIBRYD 8236804*PED Dec, 2022
VIIBRYD 8673921*PED Dec, 2022
VIIBRYD 7834020*PED Dec, 2022
VIIBRYD 8193195*PED Dec, 2022
VIIBRYD 8236804*PED Dec, 2022
VIIBRYD 8673921*PED Dec, 2022
VIIBRYD 7834020*PED Dec, 2022
VIIBRYD 8193195*PED Dec, 2022
VIIBRYD 8236804*PED Dec, 2022
VIIBRYD 8673921*PED Dec, 2022
XULTOPHY 100/3.6 8846618*PED Dec, 2022
XYREM 7895059 Dec, 2022
XYREM 8457988 Dec, 2022
XYREM 8589182 Dec, 2022
XYREM 8731963 Dec, 2022
XYWAV 8731963 Dec, 2022
Newly introduced Drug Patents
Drug Patent Patent expiry
ANNOVERA 11529308 Jun, 2039
AUVELITY 11517542 Nov, 2034
AUVELITY 11517543 Nov, 2034
AUVELITY 11524007 Nov, 2034
AUVELITY 11524008 Nov, 2034
BIJUVA 11529360 Nov, 2032
CRESEMBA 10206879 Sep, 2027
CRESEMBA 10603280 Sep, 2027
CRESEMBA 10812238 Oct, 2025
DEFINITY 11529431 Mar, 2037
DEFINITY RT 11529431 Mar, 2037
DROSPIRENONE 11504334 Jun, 2031
GIVLAARI 11530408 May, 2024
JAKAFI 10016429*PED Dec, 2028
JAKAFI 7598257*PED Jun, 2028
JAKAFI 8415362*PED Jun, 2028
JAKAFI 8722693*PED Dec, 2028
JAKAFI 8822481*PED Dec, 2028
JAKAFI 8829013*PED Dec, 2028
JAKAFI 9079912*PED Jun, 2027
JAKAFI 9814722*PED Jun, 2027
KLISYRI 11497750 Mar, 2038
KRAZATI 10689377 May, 2037
KUVAN 9216178*PED May, 2033
KUVAN 9433624*PED May, 2025
LYVISPAH 11491125 Sep, 2041
MYCAPSSA 11510963 Feb, 2036
OLUMIANT 9737469 Nov, 2031
OPZELURA 10610530*PED Dec, 2028
OPZELURA 10639310*PED Jun, 2027
OPZELURA 10758543*PED Nov, 2031
OPZELURA 10869870*PED Nov, 2031
OPZELURA 11219624*PED Nov, 2031
OPZELURA 7598257*PED Jun, 2028
OPZELURA 8415362*PED Jun, 2028
OPZELURA 8722693*PED Dec, 2028
OPZELURA 8822481*PED Dec, 2028
OPZELURA 9079912*PED Jun, 2027
OPZELURA 9974790*PED Jun, 2027
OTREXUP 11497753 Mar, 2030
PEDMARK 11510984 Jul, 2039
PLENVU 11529368 Mar, 2032
REZLIDHIA 10414752 Sep, 2035
REZLIDHIA 10532047 May, 2039
REZLIDHIA 10550098 Sep, 2035
REZLIDHIA 10959994 May, 2039
REZLIDHIA 11013733 May, 2039
REZLIDHIA 11013734 May, 2039
REZLIDHIA 11376246 May, 2039
REZLIDHIA 11497743 May, 2039
REZLIDHIA 11498913 Sep, 2035
REZLIDHIA 9834539 Sep, 2035
RHOFADE 11517560 Jun, 2035
RINVOQ 11512092 Oct, 2036
SLYND 11504334 Jun, 2031
SYMPAZAN 11541002 Jan, 2040
TAGRISSO 11524951 Jul, 2032
TASCENSO ODT 10555902 Jan, 2036
TASCENSO ODT 10925829 Jan, 2036
TASCENSO ODT 9925138 Jan, 2036
TAZVERIK 11491163 Apr, 2033
TRIKAFTA (COPACKAGED) 11517564 Dec, 2037
UPNEEQ 11541036 Dec, 2039
VANCOMYCIN HYDROCHLORIDE 11517609 Nov, 2035
VELPHORO 11234938*PED May, 2035
VELPHORO 11446252*PED May, 2035
XYOSTED (AUTOINJECTOR) 11497753 Mar, 2030
ZONISADE 11529333 Aug, 2038
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2022 GreyB Research